Innovation in Pharmaceutical Biotechnology: Comparing National Innovation Systems at the Sectoral Level

This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries. Based on rich evidence, it draws policy recommendations to foster innovation in biopharmaceuticals advocating an integrated policy approach.

Related Documents

• Sectoral Case Studies in Innovation: Pharmaceutical biotechnology
• Pharmacogenetics: Opportunities and Challenges for Health Innovation

Policy Brief : Improving Water Management: Recent OECD Experience

Securing safe and reliable water and sanitation services for all is one of the leading challenges facing sustainable development. All but a few OECD countries have connected 100% of their populations to safe water supplies, and the majority are connected to wastewater treatment. Progress has also been made in developing countries, where between 1990 and 2000 access to safe water supply rose from 73% to almost 80% of the population.

Policy Brief : Keeping Water Safe to Drink

Access to water that is safe to drink is vital to human health and to development. Recognising this, world leaders have set themselves the goal of halving by 2015 the proportion of people without sustainable access to safe drinking water and basic sanitation. This is one of the Millennium Development Goals (MDG) to reduce world poverty set out in the United Nations Millennium Declaration in the year 2000, and reaffirmed at the 2002

Guidelines for the Licensing of Genetic Inventions

These guidelines offer principles and best practices for the licensing of genetic inventions used for the purpose of human health care.

Related Documents

• Guidelines for the Licensing of Genetic Inventions
• History of OECD Genetic Licensing Project
• Genetic Inventions, Intellectual Property Rights and Licensing Practices: Evidence and Policies
• Intellectual Property

OECD Workshop on Pharmacogenetics - Workshop Presentations

Workshop Presentations

Health Technologies and Decision Making

While many countries have invested in the production of health technology assessment, evidence about its use in decision making is limited. This report analyses the barriers to, and facilitators of, evidence-based decision making in OECD health-care systems.

Workshop on Pharmacogenetics: The Intersections between Innovation, Regulation and Health Delivery,

This workshop brought together a wide range of stakeholders, including officials of regulatory agencies, representatives of relevant regional or international organizations, researchers, patients’ organizations and representative from industry.

Related Documents

• Pharmacogenetics

Dynamics of Biotechnology Research and Industry in India: Statistics, Perspectives and Key Policy Issues (STI Working Paper 2005/6)

This paper provides an inventory of biotechnology data collection in India, including an assessment of how the need for biotechnology-related statistics is being addressed. It also presents an overview of the status of biotechnology in India, with a focus on the agricultural and health sectors.

A Framework for Biotechnology Statistics

This framework is intended to provide the basis for statistical compilation work within OECD member countries and those non-member countries wishing to adopt the standards.

Statistical Definition of Biotechnology

This document sets out the provisional, single definition and list-based definitions of biotechnology.

Related Documents

• to be changed